Brooks Laboratories Ltd is a pharmaceutical manufacturing company primarily working on contract basis. Financial Results: Brooks Laboratories Ltd reported Revenues for Q1FY24
(BROOKS)
XNSE:BROOKS, XBOM:533543
Alphagraph | Brooks Laboratories Ltd (NSE: BROOKS): Q4FY23 Results Out; Total Income fell 56% YoY.
Brooks Laboratories Ltd is a pharmaceutical manufacturing company that primarily operates on a contract basis. The company specializes in the production of
Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!
Stock Data: TickerNSE: BROOKS & BSE: 533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd
Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry
Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of